Treatment with flutamide improves hyperinsulinemia in women with idiopathic hirsutism

Fertility and Sterility

Volumn 72, Issue 3, 1999, Pages 448-453

  Paoletti, Anna Maria ^a   Cagnacci, Angelo ^b   Orrù, Marisa ^a   Ajossa, Silvia ^a   Guerriero, Stefano ^a   Melis, Gian Benedetto ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Androgens; Flutamide; Hyperinsulinemia; Idiopathic hirsutism; PCOS

Indexed keywords

ANDROGEN; FLUTAMIDE; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; HIRSUTISM; HUMAN; HYPERANDROGENISM; HYPERINSULINEMIA; INSULIN METABOLISM; ORAL DRUG ADMINISTRATION; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANDROGEN ANTAGONISTS; BLOOD GLUCOSE; C-PEPTIDE; FEMALE; FLUTAMIDE; FOLLICLE STIMULATING HORMONE; GLUCOSE TOLERANCE TEST; HIRSUTISM; HUMANS; HYPERINSULINISM; INSULIN; LUTEINIZING HORMONE; POLYCYSTIC OVARY SYNDROME; PROSPECTIVE STUDIES;

EID: 0033198740     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(99)00275-7     Document Type: Article

References (25)

1. Shoupe D., Kumar D.D., Lobo R.A. Insulin resistance in polycystic ovary syndrome. Am J Obstet Gynecol. 147:1983;588-592.
2. Dunaif A., Segal K.R., Futterweit W., Dobriansky A. Profound peripheral insulin resistance, independent of obesity in polycystic ovary syndrome. Diabetes. 38:1989;1165-1174.
3. Poretsky L., Smith D., Seibel M., Pazianos A., Moses A.C., Flier J.S. Specific insulin binding sites in human ovary. J Clin Endocrinol Metab. 59:1984;809-811.
4. Barbieri R.L., Makris A., Randall W., Daniels G., Kistner R.W., Ryan K.J. Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism. J Clin Endocrinol Metab. 62:1986;904-910.
5. Plymate S.R., Matej L.A., Jones R.E., Friedl K.E. Inhibition of sex-hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin. J Clin Endocrinol Metab. 67:1988;460-464.
6. Soldani R., Cagnacci A., Yen S.S.C. Insulin, insulin-like growth factor I (IGF-I) and IGF-II enhance basal and gonadotrophin-releasing hormone-stimulated luteinizing hormone release from rat anterior pituitary cells in vitro. Eur J Endocrinol. 131:1994;641-645.
7. Holmang A., Larsson B.M., Brzezinska Z., Bjorntorp P. Effects of short-term testosterone exposure on insulin sensitivity of muscle in female rats. Am J Physiol. 262:1992;E851-E855.
8. Hennes M.M.I., Shrago E., Kissebach A.H. Receptor and postreceptor effects of free fatty acids (FFA) on hepatocyte insulin dynamics. Int J Obes. 1:1990;831-841.
9. Svedberg J., Stromblad G., Wirth A., Smith U., Bjorntorp P. Fatty acids in the portal vein of the rat regulate hepatic insulin clearance. J Clin Invest. 88:1991;2054-2058.
10. Diamanti-Kandarakis E., Mitrakon A., Hennes M.M.I., Platanissiotis D., Kaklas N., Spina J., et al. Insulin sensitivity and antiandrogenic therapy in women with polycystic ovary syndrome. Metabolism. 44:1995;525-531.
11. Dahlgren E., Landin K., Krotkiewski M., Holm G., Janson P.O. Effects of two antiandrogen treatments on hirsutism and insulin sensitivity in women with polycystic ovary syndrome. Hum Reprod. 13:1998;2706-2711.
12. Moghetti P., Tosi F., Castello R., Magnani C.M., Negri C., Brun E., et al. The insulin resistance in women with hyperandrogenism is partially reversed by antiandrogen treatment evidence that androgens impair insulin action in women. J Clin Endocrinol Metab. 81:1996;952-960.
13. Cagnacci A., Paoletti A.M., Arangino S., Melis G.B., Volpe A. Effect of ovarian suppression on glucose metabolism of young lean women with and without ovarian hyperandrogenism. Hum Reprod. 14:1999;893-897.
14. Geffner M.E., Kaplan S.A., Bersch N., Golde D.W., Landaw E.M., Chang R.J. Persistence of insulin resistance in polycystic ovarian disease after inhibition of ovarian steroid secretion. Fertil Steril. 45:1986;327-333.
15. Dunaif A., Green G., Futterweit W., Dobriansky A. Suppression of hyperandrogenism does not improve peripheral or hepatic insulin resistance in the polycystic ovary syndrome. J Clin Endocrinol Metab. 70:1990;699-704.
16. Lobo RA. Androgen excess. In: Mishell DR, Davajan V, Lobo RA, eds. Infertility, contraception and reproductive endocrinology. 3rd ed. Boston: Blackwell Scientific Publications, 1991:422-46.
17. Breckwoldt M., Zahradnik H.P., Wieacker P. Hirsutism, its pathogenesis. Hum Reprod. 4:1989;601-604.
18. Venturoli S., Porcu E., Fabbri R., Magrini O., Paradisi R., Pallotti G. Postmenarchal evolution of endocrine pattern and ovarian aspects in adolescents with menstrual irregularities. Fertil Steril. 48:1987;78-85.
19. Paoletti A.M., Cagnacci A., Depau G.F., Orrù M., Ajossa S., Melis G.B. The chronic administration of cabergoline normalizes androgen secretion and improves menstrual cyclicity in women with polycystic ovary syndrome. Fertil Steril. 66:1996;527-532.
20. Ferriman D., Gallwey J.D. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab. 21:1961;1440-1447.
21. Cusan L., Dupont A., Gomez J.-L., Tremblay R.R., Labrie F. Comparison of flutamide and spironolactone in the treatment of hirsutism a randomized controlled trial. Fertil Steril. 61:1994;281-287.
22. Tabakahashi K., Eda Y., Okada S., Abu-Musa A., Yoshino K., Kitao M. Morphological assessment of polycystic ovary using transvaginal ultrasound. Hum Reprod. 8:1993;844-849.
23. Bonora E., Zavaroni I., Coscelli C., Butturini U. Decreased hepatic insulin extraction in subjects with mild glucose intolerance. Metabolism. 32:1983;438-446.
24. Polonsky K.S., Bubenstein A.H. C-peptide as a measure of the secretion and hepatic extraction of insulin. Pitfalls and limitations. Diabetes. 33:1984;486-494.
25. Fruzzetti F., De Lorenzo D., Ricci C., Fioretti P. Clinical and endocrine effects of flutamide in hyperandrogenic women. Fertil Steril. 60:1993;806-813.